Correction Eevia Health Plc: Auditor's opinion for Financial Statements and Annual report for fiscal year 2022

Eevia Health Plc, ("Eevia" or "The Company"), released its statutory financial statements and annual report for the year 2022 yesterday, but the Auditor's opinion was omitted and a draft version of the Annual report was signed by the Board by mistake. Now the Auditors opinion is published with correct version of the financial statements.

After an omission yesterday June 12, Eevia now also publish the Auditors opinion for the fiscal year 2022. We have in the process signed a correct version of the financial statements, which has one sentence in the notes and one sentence in the annual report corrected. Therefore, the Financial statements FY2022 are hereby re-released as a correction, now also signed by the Auditor.
The financial auditor, PwC has issued an unqualified auditor's opinion for 2022.

For further information, please contact:

Stein Ulve, CEO, Eevia Health Plc                         
Email: [email protected]                     
Telephone: +358 400 22 5967


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]